aDepartment of Microbiology, Science and Research Branch, Islamic Azad University, Tehran, Iran
bDepartment of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran
cDepartment of Microbiology, Shahrekord Branch, Islamic Azad University, Shahrekord, Iran
*Corresponding author: Ashraf Kariminik, Department of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran. Email address: [email protected]
It has been reported that toll-like receptors (TLRs) are the main innate immune receptors that recognize gram-positive pathogen-associated molecular patterns (PAMPs). The molecules can induce expression of the innate immune-related molecules that are essential against the bacteria. Streptococcus mutans (S. mutans) is a potential caries-associated pathogen, and innate immunity plays a key role in inhibiting its development and the progression of inflammatory responses. Recently, the roles played by TLRs against S. mutans and the induction of inflammatory responses were evaluated by several investigations. This review article discusses updated information regarding the roles played by TLRs and their potential therapeutic effects against S. mutans.
Key words: Streptococcus mutans, Toll-like Receptors, Inflammation
Received 11 June 2023; Accepted 10 October 2023; Available online 1 January 2024
Copyright: Al-Alawi FZM, et al.
License: This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0/
It has been reported that several bacteria are resident in the human oral cavity that are responsible for dental caries and dental pulp infections.1 Among them, Streptococcus mutans (S. mutans) is the famous bacterium, which is under more investigation. S. mutans was discovered by J. Clarke more than 100 years ago.2 Due to its ability to synthesize huge quantities of extracellular glucan polymers, transport or metabolize a wide range of carbohydrates, and thrive under environmental stress conditions, such as low pH, it has been considered a potential caries-associated pathogen. S. mutans is the main organism that alters the microenvironment via forming an extracellular polysaccharide (EPS)-rich and low pH milieu to create a favorable niche for other microorganisms.3 The bacterium is implicated in other human-related disorders, including sub-acute bacterial endocarditis.4 S. mutans is classified into four serological groups, including c, e, f, and k, due to the composition of cell-surface rhamnose–glucose polysaccharide.5 S. mutans has some genotypes that are associated with great variations in the phenotypes directly related to virulence, such as the ability to form biofilm.6 In addition to genetic factors, it seems that epigenetic factors, such as small noncoding RNAs, play key roles in the ability of biofilm formation by S. mutans.7 Therefore, it appears that, although immune responses to each serotype may be different, the potential abilities of the various genotypes can also be associated with altered immune responses to S. mutans.
Additionally, S. mutans plays critical roles in other human-related disorders, such as septic shock, acute pansinusitis, periapical abscess, ulcerative colitis, gingival recession (retraction of gum tissue), bleeding gums, periodontal diseases, and tooth pulp.8 Due to the wide range of pathogenicity of S. mutans, it seems that the bacterium has a huge range of interaction with immune responses.
It has been reported that innate immunity plays a critical role against gram-positive bacteria.9 Accordingly, the molecules involved in the innate immune responses against gram-positive bacteria can be considered as the main factors against S. mutans.10 It has been reposted that toll-like receptors (TLRs) are the main pathogen recognition receptors that are expressed either on the cell membrane or intracytoplasmic vesicles.11–13 TLRs are categorized into a family comprising 13 members, while TLR1 to TLR10 are expressed in humans only.14 The molecules are expressed in dimmer format, including heterodimers of TLR1/TLR2 and TLR6/TLR2, and homodimers of TLR2/TLR2, TLR3/TLR3, TLR4/TLR4, TLR5/TLR5, TLR7/TLR7, TLR8/TLR8, and TLR9/TLR9.14,15 The molecules recognize several molecules and activate the innate immune responses.16,17 For example, the main ligands for TLR1/TLR2, TLR6/TLR2, TLR2/TLR2, TLR3/TLR3, TLR4/TLR4, TLR5/TLR5, TLR7/TLR7, TLR8/TLR8, and TLR9/TLR9 are bacterial lipopeptides, bacterial lipopeptides, bacterial peptidoglycan, double-stranded RNA, lipopolysaccharide, bacterial flagellin, single-stranded RNA, single-stranded RNA, and CPG DNA, respectively.16 However, TLRs use several intracellular signaling pathways to induce transcription from immune-related genes in innate immune cells.16 For example, TLR3/TLR3 homodimer uses TIR-domain-containing adapter-inducing interferon-β (TRIF)-dependent signaling pathways,17,18 while TLR4/TLR4 homodimer uses both TRIF and myeloid differentiation primary response 88 (MYD88)-dependent pathways.19 Other TLRs use the MyD88-dependent pathway only.14 The pathway activations result in the activation of some transcription factors, which are the molecules responsible for transcription from innate immunity-related genes. Accordingly, some transcription factors, such as nuclear factor kappa light chain enhancer of activated B cells (NF-κB), activator protein 1 (AP-1), and interferon regulatory factor 3 (IRF3), are important factors for transcription from the genes.20 Cytokines, pro-inflammatory molecules, adhesion molecules, and the major histocompatibility complex (MHC) are the main molecules that are expressed following activation of TLRs.21 The immune-related molecules play a key role against gram-positive bacteria. Hence, due to the various ranges of the ligands that are recognized by TLRs and their important roles against gram-positive bacteria, it has been hypothesized that these molecules play a key role against S. mutans.
Previous investigations have proved that TLRs are expressed on the resident dental pulp cells, including normal human odontoblasts, dental pulp tissue, dental pulp stem cells (DPSCs), and immune cells.22 In addition, DPSCs can be considered as an important part of the innate immune response against S. mutans.22 Previous investigations have revealed that S. mutans significantly activates DPSCs via interactions with TLR4.23,24 In another words, DPSCs can recognize and respond to S. mutans via TLR4. Therefore, it seems that TLRs are the main receptors for non-immunologic cells to develop into dental pulp normally. However, these molecules are the main immune cell receptors that are resident in the tissue. Accordingly, the receptors may either participate in the induction of immune responses against S. mutans to inhibit its growth or in the induction of inflammation and then tissue damage. In agreement with the hypothesis, it has been reported that the lipoteichoic acid of S. mutans interacts with TLR2 and induces inflammatory mediators in murine macrophages, including the production of tumor necrosis factor-alpha (TNF-α) and nitric oxide (NO) in a dose-dependent manner.25 The inflammatory roles played by TLR2 in the recognition of S. mutans and production of interleukin-6 (IL-6), IL-8, and monocyte chemoattractant protein-1 (MCP-1) have been demonstrated in another vitro study.26 Additional investigations also confirmed the roles played by TLRs against S. mutans through an in vivo investigation.27,28 They reported that TLRs are the main inducers of inflammation in the dental pulp tissues via recognition of S. mutans–related ligands.27,28 The pro-inflammatory roles played by TLRs against S. mutans and the induction of some pro-inflammatory diseases, such as periodontitis, have also been documented by Yoshioka et al.29 Animal models revealed that S. mutans is the microorganism responsible for the induction of balloon angioplasty (BA) injury via upregulation of TLR4.30 Hajishengallis et al. reported that S. mutans protein AgI/II is the primary molecule for cytokine release during atherosclerotic disease in dependent of CD14 and TLR4.31 To confirm the pro-inflammatory roles of S. mutans via interactions with TLRs, Horst et al. reported that transforming growth factor-beta1 (TGF-β1) is a main factor for regulation of pro-inflammatory reactions in odontoblasts against S. mutans via down-regulation of TLR2 and TLR4.32
Due to the results reported previously, it appears that TLRs are the main components in the inflammation together with S. mutans. In another words, the main cause of several pro-inflammatory-related gum and dental disorders may be the interaction of S. mutans antigens with TLRs. Accordingly, using some TLR antagonists may be considered as future immunotherapies against gum and dental inflammations. Figure 1 illustrates the main roles played by TLRs in the induction of inflammation following infection by S. mutans.
Figure 1 The roles played by TLRs in the induction of inflammation during chronic inflammation with Streptococcus mutans. The figure illustrates that chronic exposure of S. mutans antigens to both cell surface and intra-vesicular TLRs can be associated with expression of pro-inflammatory molecules, which the main responsible factors for inflammation induction and its-related disorders.
The protective roles played by TLRs against S. mutans have also been documented previously. For example, it has been demonstrated that Pam3CSK4 and monophosphoryl lipid A are the important synthetic ligands for TLR1/TLR2 heterodimer and TLR4/TLR4 homodimer, respectively.33 Accordingly, using the ligands as adjuvants significantly increased the immune responses against recombinant proteins of S. mutans.34 Additionally, the recombinant saliva-binding region (SBR) of S. mutans can induce the production of mucosal IgA in a TLR2, TLR4, and MyD88-dependent manner.35 It has been demonstrated that the Myd88 signaling pathway includes interleukin-1 receptor-associated kinase 4 (IRAK4), IRAK1, tumor necrosis factor receptor (TNFR)-associated factor 6 (TRAF6), and finally activations of some transcription factors, such as IRFs, NF-κB, and AP-1.16,17 The transcription factors are the molecules responsible for induction of inflammation following the recognition of S. mutans antigens by TLRs. Figure 2 illustrates the signaling pathways that lead to the induction of inflammation by S. mutans in dependent of TLRs. Xu et al. also confirmed the results and revealed that saliva-binding region (SBR) of S. mutans antigen can activate dendritic cells via interactions with TLR4.36 Interestingly, the study demonstrated that activation of mitogen-activated protein kinases (MAPKs), including extracellular signal-regulated kinase 1/2 (ERK), c-Jun NH2-terminal kinase (JNK), and p38, by TLR4, is responsible for the activation of dendritic cells by intracellular signaling molecules.36 The critical roles played by TLRs against S. mutans have also been proven by several investigations. Conti et al. reported that using herbal drugs that are associated with increased expression of TLRs and their related transcription factors, such as NF-κB, can increase immune responses against S. mutans.37 Another investigation revealed that following the interaction of TLR2 with the antigens S. mutans, human odontoblast-like cells produce NO with antibacterial activity.38 Hong et al. also confirmed the roles played by TLR2 against S. mutans.39 They revealed that lipoteichoic acid in S. mutans is the main ligand for activation of TLR2 signaling pathways.39 The critical roles played by TLR2 against S. mutans have also been demonstrated by Japanese investigators.40 S. mutans wall-associated protein A is another ligand that promotes TLR4-induced dendritic cell (DC) maturation and functions.41 Accordingly, the protein induces maturation of DCs via the NF-κB and MAPK signaling pathways and then upregulation of CD80/86, CD40, major histocompatibility (MHC) II, IL-12, IL-6, and TNF-α by the cells.41 An in vitro study revealed that S. mutans stimulates TLR2 and TLR4 receptors, which are associated with the activations of ERK/p38/JNK and NF-κB, respectively.42 Thus, it appears that S. mutans stimulates TLRs in various signaling pathways. In addition to the direct interaction of S. mutans antigens with TLRs, conjugation of S. mutans antigens with other TLR ligands can increase immune responses against the bacterium. For instance, Sun et al. showed that conjugation of E. coli flagellin and S. mutans PAc significantly interacts with the TLR5/TLR5 homodimer and increases the efficacy of the anti-caries mucosal vaccine.43 The potential roles played by TLR3 in inducing of humoral immunity against S. mutans have also been demonstrated by Nakamura et al.44 Interestingly, some investigations revealed that although TLRs are not responsible for the detection of S. mutans proteins in some cases, the cross-talks between intracellular signaling, such as focal adhesion kinase (FAK) and MyD88, can be considered as the main phenomenon for induction of inflammation and immune responses against S. mutans.45 Similarly, Semaan et al. showed that Etk/BMX, a Btk family tyrosine kinase, and Mal are the main linkers for cross-talk between MyD88 and FAK pathways.46 It has also been demonstrated that TLRs are the molecules responsible for producing phospholipase A2 and platelet activation factor (PAF), via recognition of S. mutans PAMPs, and activation of inflammation.47 Therefore, it appears that TLRs and their signaling pathways can also participate against S. mutans, either directly or indirectly. The molecular mechanisms used by TLRs in the pathogenesis of S. mutans are illustrated in Figure 2.
Figure 2 The molecular mechanisms used by TLRs in the pathogenesis of S. mutans. TLRs use Myd88 and TRIF-dependent pathways to activate transcription factors to transcript from pro-inflammatory cytokines, and nitric oxide synthesize (NOS) and type 1 interferons. TLRs also induce the production of phospholipase A2 and PAF to induce inflammation in dependent of S. mutans.
Collectively, it seems that TLRs are the main parts of immune response puzzles against S. mutans. Due to the important roles played by the molecules against the bacterium, their ligands may be considered as potential adjuvants in the future vaccines to control the cariogenic bacterium.
Although TLRs are the main inducers of immune responses against S. mutans, some investigations revealed that the bacterium uses some TLRs to induce immune tolerance against its antigens. For example, Saeki et al. reported that S. mutans interacts with TLR2 to develop of regulatory T lymphocytes.48 Another investigation by Park et al. revealed that S. mutans antigens can induce apoptosis in immune cells via interactions with TLRs in a dose-dependent manner.49 Additionally, it appears that coinfection with other pathogenic or opportunistic bacteria may be a critical factor in altering the effects of S. mutans on immune cell functions. For example, Zhang et al. reported that during coinfection, Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), but not S. mutans, significantly participated in the induction of TLRs-mediated inflammation and the production of atherosclerotic plaque in animal models.50 TLR9 is another candidate to regulate immune responses against S. mutans via recognition of periodontal bacterial DNA.51
Collectively, it appears that TLRs are the main innate immunity receptors that participate in the induction of immune responses against S. mutans. However, it may be hypothesized that the doses of S. mutans antigens, the immune cell target, coinfection with other pathogenic or opportunistic bacteria, and the type of TLRs, for example, TLR9, are the main factors that determine the outcome of immune responses against S. mutans. Additionally, as mentioned previously, it appears that S. mutans stimulates different signaling pathways depending of the TLR type. The main factors that determine the protective or pro-inflammatory roles played by TLRs against S. mutans are yet to be clarified. However, the authors propose that genetic and epigenetic factors are the critical factors in determining the outcome of the infection. Additionally, due to the fact that the infection with S. mutans is a chronic form of the bacterial infection, immunological exhaustion may be a main factor in the induction of pathological inflammation in the dental pulps and gums of the teeth. Due to the critical roles played by TLRs against S. mutans, it seems that using TLR ligands as adjuvants in association with S. mutans antigens can be considered for designing vaccines against the bacterium. However, the majority investigations were performed on two main TLRs, TLR2 and TLR4. So, future investigations need to be directed at using the ligands for other TLRs.
1. Zaatout N. Presence of non-oral bacteria in the oral cavity. Arch Microbiol. 2021;203(6):2747–60. 10.1007/s00203-021-02300-y
2. Clarke JK. On the bacterial fin the etiology of dental caries. Br J Exp Pathol. 1924;5(3):141–7.
3. Klein MI, Hwang G, Santos PH, Campanella OH, Koo H. Streptococcus mutans-derived extracellular matrix in cariogenic oral biofilms. Front Cell Infect Microbiol. 2015;5:10. 10.3389/fcimb.2015.00010
4. Schmalzle SA. A classic and fatal case of Streptococcus mutans subacute bacterial endocarditis; A now potentially underappreciated disease. IDCases. 2020;19:e00701. 10.1016/j.idcr.2020.e00701
5. Nakano K, Ooshima T. Serotype classification of Streptococcus mutans and its detection outside the oral cavity. Future Microbiol. 2009;4(7):891–902. 10.2217/fmb.09.64
6. Hossain MS, Alam S, Nibir YM, Tusty TA, Bulbul SM, Islam M. Genotypic and phenotypic characterization of Streptococcus mutans strains isolated from patients with dental caries. Iran J Microbiol. 2021;13(4):449–57. 10.18502/ijm.v13i4.6968
7. Yin L, Zhu W, Chen D, Zhou Y, Lin H. Small noncoding RNA sRNA0426 is involved in regulating biofilm formation in Streptococcus mutans. Microbiologyopen. 2020;9(9):6. 10.1002/mbo3.1096
8. Greenwood D, Slack RC, Barer MR, Irving WL. Medical microbiology e-book: A guide to microbial infections: Pathogenesis, immunity, laboratory diagnosis and control. With STUDENT CONSULT Online Access. 12 ed. Elsevier Health Sciences; 2012.
9. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol. 1999;163(1):1–5.
10. Song Y, Na HS, Park E, Park MH, Lee HA, Chung J. Streptococcus mutans activates the AIM2, NLRP3 and NLRC4 inflammasomes in human THP-1 macrophages. Int J Oral Sci. 2018;10(3):23. 10.1038/s41368-018-0024-z
11. Radman M, Golshiri A, Shamsizadeh A, Zainodini N, Bagheri V, Arababadi MK, et al. Toll-like receptor 4 plays significant roles during allergic rhinitis. Allergol Immunopathol (Madr). 2015;43(4):416–20. 10.1016/j.aller.2014.04.006
12. Sepehri Z, Kiani Z, Alavian SM, Arababadi MK, Kennedy D. The link between TLR7 signaling and hepatitis B virus infection. Life Sci. 2016;158:63–9. 10.1016/j.lfs.2016.06.026
13. Naghib M, Kariminik A, Kazemi Arababadi M. Tlr2, as a pathogen recognition receptor, plays critical roles in hepatitis B outcome. Viral Immunol. 2022;35(1):15–23. 10.1089/vim.2021.0141
14. Sameer AS, Nissar S. Toll-like receptors (TLRs): Structure, functions, signaling, and role of their polymorphisms in colorectal cancer susceptibility. Biomed Res Int. 2021;2021:1157023. 10.1155/2021/1157023
15. Ahmadishoar S, Kariminik A. Toll-like receptor 2 and its roles in immune responses against Legionella pneumophila. Life Sci. 2017;188:158–62. 10.1016/j.lfs.2017.09.009
16. De Nardo D. Toll-like receptors: Activation, signalling and transcriptional modulation. Cytokine. 2015;74(2):181–9. 10.1016/j.cyto.2015.02.025
17. Douzandeh-Mobarrez B, Kariminik A, Kazemi Arababadi M, Kheirkhah B. TLR9 in the human papilloma virus infections: Friend or foe? Viral Immunol. 2022; 5(7):457–64. 10.1089/vim.2021.0223
18. Douzandeh-Mobarrez B, Kariminik A, Arababadi MK, Kheirkhah B. Upregulation of Toll-like receptors 2, 5, 7, and 9 in the cervical epithelial cells of Iranian women infected with high-risk human papilloma virus. Clin Lab. 2022;68(11). 10.7754/Clin.Lab.2022.220120
19. Asadzadeh Manjili F, Yousefi-Ahmadipour A, Kazemi Arababadi M. The roles played by TLR4 in the pathogenesis of multiple sclerosis; A systematic review article. Immunol Lett. 2020;220:63–70. 10.1016/j.imlet.2020.02.004
20. Kawai T, Akira S. Signaling to NF-kappaB by Toll-like receptors. Trends Mol Med. 2007;13(11):460–9. 10.1016/j.molmed.2007.09.002
21. Kawasaki T, Kawai T. Toll-like receptor signaling pathways. Front Immunol. 2014;5:461. 10.3389/fimmu.2014.00461
22. Andrukhov O. Toll-like receptors and dental mesenchymal stromal cells. Front Oral Health. 2021;2:648901. 10.3389/froh.2021.648901
23. Liu Y, Gao Y, Zhan X, Cui L, Xu S, Ma D, et al. TLR4 activation by lipopolysaccharide and Streptococcus mutans induces differential regulation of proliferation and migration in human dental pulp stem cells. J Endod. 2014;40(9):1375–81. 10.1016/j.joen.2014.03.015
24. Ramenzoni LL, Zuellig RA, Hussain A, Lehmann R, Heumann C, Attin T, et al. Bacterial supernatants elevate glucose-dependent insulin secretion in rat pancreatic INS-1 line and islet β-cells via PI3K/AKT signaling. Mol Cell Biochem. 2019;452(1–2):17–27. 10.1007/s11010-018-3408-7
25. Hong SW, Baik JE, Kang SS, Yun CH, Seo DG, Han SH. Lipoteichoic acid of Streptococcus mutans interacts with Toll-like receptor 2 through the lipid moiety for induction of inflammatory mediators in murine macrophages. Mol Immunol. 2014;57(2):284–91. 10.1016/j.molimm.2013.10.004
26. Nagata E, Oho T. Invasive Streptococcus mutans induces inflammatory cytokine production in human aortic endothelial cells via regulation of intracellular toll-like receptor 2 and nucleotide-binding oligomerization domain 2. Mol Oral Microbiol. 2017;32(2):131–41. 10.1111/omi.12159
27. Gómez-García AP, López-Vidal Y, Pinto-Cardoso S, Aguirre-García MM. Overexpression of proinflammatory cytokines in dental pulp tissue and distinct bacterial microbiota in carious teeth of Mexican Individuals. Front Cell Infect Microbiol. 2022;12:958722. 10.3389/fcimb.2022.958722
28. Hirao K, Yumoto H, Takahashi K, Mukai K, Nakanishi T, Matsuo T. Roles of TLR2, TLR4, NOD2, and NOD1 in pulp fibroblasts. J Dent Res. 2009;88(8):762–7. 10.1177/0022034509341779
29. Yoshioka H, Yoshimura A, Kaneko T, Golenbock DT, Hara Y. Analysis of the activity to induce toll-like receptor (TLR)2-and TLR4-mediated stimulation of supragingival plaque. J Periodontol. 2008;79(5):920–8. 10.1902/jop.2008.070516
30. Kesavalu L, Lucas AR, Verma RK, Liu L, Dai E, Sampson E, et al. Increased atherogenesis during Streptococcus mutans infection in ApoE-null mice. J Dent Res. 2012;91(3):255–60. 10.1177/0022034511435101
31. Hajishengallis G, Sharma A, Russell MW, Genco RJ. Interactions of oral pathogens with toll-like receptors: Possible role in atherosclerosis. Ann Periodontol. 2002;7(1):72–8. 10.1902/annals.2002.7.1.72
32. Horst OV, Tompkins KA, Coats SR, Braham PH, Darveau RP, Dale BA. TGF-beta1 Inhibits TLR-mediated odontoblast responses to oral bacteria. J Dent Res. 2009;88(4):333–8. 10.1177/0022034509334846
33. Funderburg NT, Jadlowsky JK, Lederman MM, Feng Z, Weinberg A, Sieg SF. The Toll-like receptor 1/2 agonists Pam(3) CSK(4) and human β-defensin-3 differentially induce interleukin-10 and nuclear factor-κB signalling patterns in human monocytes. Immunology. 2011;134(2):151–60. 10.1111/j.1365-2567.2011.03475.x
34. Bi Y, Xu Q, Su L, Xu J, Liu Z, Yang Y, et al. The combinations Chitosan-Pam(3)CSK(4) and Chitosan-Monophosphoryl lipid A: Promising immune-enhancing adjuvants for anticaries vaccine PAc. Infect Immun. 2019;87(12):e00651-19. 10.1128/IAI.00651-19
35. Salam MA, Katz J, Michalek SM. Role of Toll-like receptors in host responses to a virulence antigen of Streptococcus mutans expressed by a recombinant, attenuated Salmonella vector vaccine. Vaccine. 2010;28(31):4928–36. 10.1016/j.vaccine.2010.05.039
36. Xu Q, Katz J, Zhang P, Ashtekar AR, Gaddis DE, Fan M, et al. Contribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation. Infect Immun. 2011;79(9):3792–800. 10.1128/IAI.05338-11
37. Conti BJ, Santiago KB, Cardoso EO, Freire PP, Carvalho RF, Golim MA, et al. Propolis modulates miRNAs involved in TLR-4 pathway, NF-κB activation, cytokine production and in the bactericidal activity of human dendritic cells. J Pharm Pharmacol. 2016;68(12):1604–12. 10.1111/jphp.12628
38. Farges JC, Bellanger A, Ducret M, Aubert-Foucher E, Richard B, Alliot-Licht B, et al. Human odontoblast-like cells produce nitric oxide with antibacterial activity upon TLR2 activation. Front Physiol. 2015;6:185. 10.3389/fphys.2015.00185
39. Hong SW, Seo DG, Baik JE, Cho K, Yun CH, Han SH. Differential profiles of salivary proteins with affinity to Streptococcus mutans lipoteichoic acid in caries-free and caries-positive human subjects. Mol Oral Microbiol. 2014;29(5):208–18. 10.1111/omi.12057
40. Segawa T, Saeki A, Hasebe A, Arimoto T, Kataoka H, Yokoyama A, et al. Differences in recognition of wild-type and lipoprotein-deficient strains of oral Streptococci in vitro and in vivo. Pathog Dis. 2013;68(3):65–77. 10.1111/2049-632X.12049
41. Li H, Wang D. Streptococcus mutans wall-associated protein A promotes TLR4-induced dendritic cell maturation. Scand J Immunol. 2014;80(2):121–6. 10.1111/sji.12194
42. Kim JS, Kim KD, Na HS, Jeong SY, Park HR, Kim S, et al. Tumor necrosis factor-α and interleukin-1β expression pathway induced by Streptococcus mutans in macrophage cell line RAW 264.7. Mol Oral Microbiol. 2012;27(3):149–59. 10.1111/j.2041-1014.2012.00639.x
43. Sun Y, Shi W, Yang JY, Zhou DH, Chen YQ, Zhang Y, et al. Flagellin-PAc fusion protein is a high-efficacy anti-caries mucosal vaccine. J Dent Res. 2012;91(10):941–7. 10.1177/0022034512457684
44. Nakamura T, Iwabuchi Y, Hirayama S, Narisawa N, Takenaga F, Nakao R, et al. Roles of membrane vesicles from Streptococcus mutans for the induction of antibodies to glucosyltransferase in mucosal immunity. Microb Pathog. 2020;149:104260. 10.1016/j.micpath.2020.104260
45. Zeisel MB, Druet VA, Sibilia J, Klein JP, Quesniaux V, Wachsmann D. Cross talk between MyD88 and focal adhesion kinase pathways. J Immunol. 2005;174(11):7393–7. 10.4049/jimmunol.174.11.7393
46. Semaan N, Alsaleh G, Gottenberg JE, Wachsmann D, Sibilia J. Etk/BMX, a Btk family tyrosine kinase, and Mal contribute to the cross-talk between MyD88 and FAK pathways. J Immunol. 2008;180(5):3485–91. 10.4049/jimmunol.180.5.3485
47. Bhowmick R, Clark S, Bonventre JV, Leong JM, McCormick BA. Cytosolic phospholipase A(2)α promotes pulmonary inflammation and systemic dduring Streptococcus pneumoniae infection. Infect Immun. 2017;85(11):e00280–17. 10.1128/IAI.00280-17
48. Saeki A, Segawa T, Abe T, Sugiyama M, Arimoto T, Hara H, et al. Toll-like receptor 2-mediated modulation of growth and functions of regulatory T cells by oral streptococci. Mol Oral Microbiol. 2013;28(4):267–80. 10.1111/omi.12023
49. Park OJ, Kim AR, So YJ, Im J, Ji HJ, Ahn KB, et al. Induction of apoptotic cell death by oral streptococci in human periodontal ligament cells. Front Microbiol. 2021;12:738047. 10.3389/fmicb.2021.738047
50. Zhang T, Kurita-Ochiai T, Hashizume T, Du Y, Oguchi S, Yamamoto M. Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Microbiol. 2010;59(2):143–51. 10.1111/j.1574-695X.2010.00674.x
51. Taubman MA, Han X, Larosa KB, Socransky SS, Smith DJ. Periodontal bacterial DNA suppresses the immune response to mutans streptococcal glucosyltransferase. Infect Immun. 2007;75(8):4088–96. 10.1128/IAI.00623-07